ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

No reported Net Change in Cash figures are available to summarize.

Net Change in Cash history

Currency unavailable · from the cash flow

No Net Change in Cash data reported for this period type.

Net Change in Cash vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Net Change in Cash for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$301.55M USD+384.7%—420.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$116.23M USD-220.5%+11.8%362.3%
BNTCBenitec Biopharma Inc.LTM Mar 2026$81.23M USD-9.2%——
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$60.43M USD-15.4%—133.2%
SLNSilence Therapeutics plcLTM Mar 2026$59.21M USD—+49.3%6425.7%
PRQRProQR Therapeutics N.V.LTM Mar 2026€53.17M EUR-213.8%-24.9%395.5%
PRMEPrime Medicine, Inc.LTM Mar 2026$28.14M USD+1537.1%—697.6%
MGTXMeiraGTx Holdings plcLTM Mar 2026$5.19M USD+110.1%+19.1%6.5%
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-9.2%+15.5%378.9%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.